Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$12.30
-4.43%today
MKT CAP
$1.0B
-3.0% · 1Y
Earnings History
+14.4%
+63.9%
+57.5%
+7.3%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$12.30
Low
$13.00
Analyst Mean
$23.70
High
$29.00
10 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E8.4x
EV/EBITDA-13.9x
Price/Sales-
Dividend Yield-
Revenue Growth YoY+104.4%
Earnings Growth YoY-
Revenue Growth QoQ+1.2%
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin84.9%
Operating Margin-26.5%
Net Margin-76.8%
ROE-
Debt / Equity-
Free Cash Flow$-77,528,624
Insider Ownership4.6%
Institutional Ownership83.8%
Short % of Float12.60%
Days to Cover8.8d
1 Week+8.3%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PARIKH ASIT | Director | Stock | 40,000 | $0.00 | $0.00M | 2026-03-10 |
| BREEDLOVE ROBERT CHARLES | Officer | Stock | 15,790 | $0.00 | $0.00M | 2026-02-27 |
| BASTA STEVEN L | Chief Executive Officer | Stock | 12,362 | $0.00 | $0.00M | 2026-02-10 |
| COOK ANNE MARIE | Officer | Stock | 3,461 | $0.00 | $0.00M | 2026-02-10 |
| PARIKH ASIT | Director | Stock | 80,500 | $0.00 | $0.00M | 2026-01-23 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | institution | 15.63% | $0.15B | +0.00% | 2025-12-31 |
| Medicxi Ventures Management (Jersey) Ltd | institution | 9.36% | $0.09B | +0.00% | 2026-03-31 |
| Invesco Ltd. | institution | 4.92% | $0.05B | +1.44% | 2025-12-31 |
| Blackrock Inc. | institution | 4.46% | $0.04B | +4.50% | 2025-12-31 |
| Carlyle Group Inc. | institution | 4.38% | $0.04B | +0.00% | 2025-12-31 |
| Vanguard Group Inc | institution | 3.98% | $0.04B | -1.19% | 2025-12-31 |
| Ensign Peak Advisors, Inc | institution | 2.95% | $0.03B | -6.04% | 2025-12-31 |
| AIM Intl Mutual Fd.s -Invesco Global Fd. | fund | 2.94% | $0.03B | +18.58% | 2026-01-31 |
| Millennium Management Llc | institution | 2.61% | $0.03B | -59.02% | 2025-12-31 |
| NEA Management Company, LLC | institution | 2.46% | $0.02B | +0.00% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.28% | $0.02B | -7.54% | 2025-12-31 |
| 683 Capital Management LLC | institution | 2.24% | $0.02B | -1.94% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 1.39% | $0.01B | +13.09% | 2026-03-31 |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | fund | 1.21% | $0.01B | +100.00% | 2026-03-31 |
| WASATCH FUNDS TRUST-Wasatch Micro Cap Fund | fund | 1.01% | $0.01B | +7.67% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.62% | $0.01B | -3.48% | 2025-12-31 |
| WASATCH FUNDS TRUST-Wasatch Ultra Growth Fund | fund | 0.62% | $0.01B | -12.20% | 2026-03-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | fund | 0.50% | $0.00B | +10.00% | 2026-03-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | fund | 0.49% | $0.00B | +0.89% | 2026-02-28 |
| iShares Trust-iShares Biotechnology ETF | fund | 0.45% | $0.00B | +5.01% | 2026-03-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for PHAT.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.